BSE filing, BSE: 524548. Summary written from the filing by ALFA Finder's alert engine.
Sharma East India Hospitals & Medical Research Ltd: key numbers
- Share price
- ₹80.48
- Market cap
- ₹26.43 Cr
- Revenue (annual)
- ₹35.93 Cr
- Net profit (annual)
- ₹1.24 Cr
- P/E (TTM)
- 22.3×Sector 52.0×
- Promoter holding
- 53.63%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sharma East India Hospitals & Medical Research Ltd
All →Sharma East India Hospitals & Medical Research Other Announcement
Sharma East India Hospitals filed a Reg 74(5) SEBI (DP) dematerialization certificate for Q2 FY27. It is a routine RTA compliance confirmation with no new business content.
Sharma East India Hospitals & Medical Research Annual General Meeting
Sharma East India Hospitals & Medical Research Ltd. conducted its 37th Annual General Meeting on September 30, 2026, through video conferencing to transact ordinary business resolutions.
Sharma East India Hospitals & Medical Research Annual Report
Sharma East India Hospitals has filed its 37th Annual Report for FY 2025-2026. The report includes details concerning the upcoming Annual General Meeting.
Sharma East India Hospitals & Medical Research Annual General Meeting
The company approved its Annual Report and scheduled the 37th Annual General Meeting for September 30, 2026. Various AGM-related procedural dates were also finalized.
Sharma East India Hospitals & Medical Research Q1 FY27 Results: Net Profit ₹0.3 Cr, Up 0.0% YoY
Sharma East India Hospitals & Medical Research Ltd reported revenue from operations of ₹10.8 Cr (+13.7% YoY) and net profit of ₹0.3 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr · +0.0% YoY
Sharma East India Hospitals & Medical Research Other Announcement
The company has filed its quarterly shareholding pattern as per SEBI regulations. This document discloses the current distribution of shareholding among various categories.
Other board meeting date announcements
All →Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.
EPL Board Meeting Date
EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.